Skip To Main Content
Maha Javaid on Muck Rack

Maha Javaid

As seen in: Daily Times, eCancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maha

Contact Maha, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Outcomes of first-line treatment and their association with pretreatment neutrophil-to-lymphocyte ratio in patients with advanced renal cell carcinoma: insights

|
By Mirza Rameez Samar, Maha Javaid, Nida Zehra, Nawazish Zehra
| eCancer Verified
Background: Renal cell carcinomas (RCCs) are renal parenchymal neoplasms that contribute to <5% of cancer cases worldwide. Within the diverse group of renal tumours, clear cell carcinoma is the most common subtype. The recommended first-line treatment for metastatic disease is a tyrosine kinase inhibitor given either as monotherapy or in combination with an immune checkpoint inhibitor, based on improved survival outcomes.
Open in Who Shared Issue with article?

Behind the scene: The secret story of failure

|
By Maha Javaid
| Daily Times Verified
“Success” it’s the most glorified goal and over used word in today’s world. Whenever anyone achieves something in their life they become a success story and automatically everything related to that person’s life is glamorized and portrayed in a way that somehow leads to their success. Being successful is a drug that makes one run after things that at times they don’t really want. It’s a sad reality but people have started to measure their success by looking at what other people have.
Open in Who Shared Issue with article?
See all 2 articles